Syndax Pharmaceuticals Inc - Common Stock (SNDX)

CUSIP: 87164F105

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / Common Stock
Shares outstanding
86,727,396
Total 13F shares
15,460,307
Share change
+135,040
Total reported value
$68,794,733
Put/Call ratio
13%
Price per share
$4.45
Number of holders
73
Value change
-$2,725,288
Number of buys
40
Number of sells
33

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 87164F105?
CUSIP 87164F105 identifies SNDX - Syndax Pharmaceuticals Inc - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of SNDX - Syndax Pharmaceuticals Inc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
3.9%
3,340,546
$26,992,000 30 Sep 2018
13F
MPM ASSET MANAGEMENT LLC
13F
Company
2.5%
2,168,691
$17,523,000 30 Sep 2018
13F
BlackRock Finance, Inc.
13F
Company
2%
1,757,844
$14,202,000 30 Sep 2018
13F
BVF INC/IL
13F
Company
1.4%
1,233,618
$9,968,000 30 Sep 2018
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.92%
795,767
$6,428,000 30 Sep 2018
13F
VANGUARD GROUP INC
13F
Company
0.85%
736,604
$5,951,000 30 Sep 2018
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.7%
608,038
$4,913,000 30 Sep 2018
13F
683 Capital Management, LLC
13F
Company
0.6%
521,000
$4,210,000 30 Sep 2018
13F
ORBIMED ADVISORS LLC
13F
Company
0.5%
437,000
$3,531,000 30 Sep 2018
13F
FMR LLC
13F
Company
0.4%
348,653
$2,817,000 30 Sep 2018
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.32%
279,300
$2,257,000 30 Sep 2018
13F
MORGAN STANLEY
13F
Company
0.31%
269,595
$2,178,000 30 Sep 2018
13F
Tekla Capital Management LLC
13F
Company
0.23%
200,000
$1,616,000 30 Sep 2018
13F
STATE STREET CORP
13F
Company
0.23%
195,858
$1,583,000 30 Sep 2018
13F
MACQUARIE GROUP LTD
13F
Company
0.21%
180,000
$1,454,000 30 Sep 2018
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.2%
173,431
$1,401,000 30 Sep 2018
13F
Sofinnova Investments, Inc.
13F
Company
0.2%
173,112
$1,398,000 30 Sep 2018
13F
NORTHERN TRUST CORP
13F
Company
0.2%
172,802
$1,396,000 30 Sep 2018
13F
Point72 Asset Management, L.P.
13F
Company
0.2%
170,000
$1,374,000 30 Sep 2018
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.18%
156,513
$1,265,000 30 Sep 2018
13F
UNITED SERVICES AUTOMOBILE ASSOCIATION
13F
Company
0.15%
126,663
$1,023,000 30 Sep 2018
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.12%
101,800
$823,000 30 Sep 2018
13F
Boxer Capital, LLC
13F
Company
0.12%
100,000
$808,000 30 Sep 2018
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
0.12%
100,000
$808,000 30 Sep 2018
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.11%
98,390
$795,000 30 Sep 2018
13F
DEUTSCHE BANK AG\
13F
Company
0.1%
88,213
$712,000 30 Sep 2018
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.08%
66,399
$537,000 30 Sep 2018
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.07%
63,915
$516,000 30 Sep 2018
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.07%
58,784
$475,000 30 Sep 2018
13F
CITADEL ADVISORS LLC
13F
Company
0.07%
58,055
$469,000 30 Sep 2018
13F
Caption Management, LLC
13F
Company
0.06%
52,000
$421,000 30 Sep 2018
13F
Bank of New York Mellon Corp
13F
Company
0.06%
49,762
$402,000 30 Sep 2018
13F
ALPS ADVISORS INC
13F
Company
0.05%
41,328
$334,000 30 Sep 2018
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.04%
33,312
$269,000 30 Sep 2018
13F
TEACHERS ADVISORS, LLC
13F
Company
0.03%
25,344
$205,000 30 Sep 2018
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.03%
24,182
$196,000 30 Sep 2018
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.03%
23,065
$186,000 30 Sep 2018
13F
Telemetry Investments, L.L.C.
13F
Company
0.03%
23,053
$186,000 30 Sep 2018
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.03%
22,688
$183,000 30 Sep 2018
13F
OPPENHEIMER & CO INC
13F
Company
0.02%
19,588
$158,000 30 Sep 2018
13F
SIMPLEX TRADING, LLC
13F
Company
0.02%
18,438
$148,000 30 Sep 2018
13F
BARCLAYS PLC
13F
Company
0.02%
17,933
$144,000 30 Sep 2018
13F
Claraphi Advisory Network, LLC
13F
Company
0.02%
16,000
$129,000 30 Sep 2018
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.02%
15,512
$125,000 30 Sep 2018
13F
LPL Financial LLC
13F
Company
0.02%
14,130
$114,000 30 Sep 2018
13F
RHUMBLINE ADVISERS
13F
Company
0.02%
14,060
$114,000 30 Sep 2018
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.02%
13,700
$111,000 30 Sep 2018
13F
C WorldWide Group Holding A/S
13F
Company
0.02%
13,227
$107,000 30 Sep 2018
13F
Squarepoint Ops LLC
13F
Company
0.01%
12,298
$99,000 30 Sep 2018
13F
ProShare Advisors LLC
13F
Company
0.01%
11,240
$91,000 30 Sep 2018
13F

Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock (SNDX) as of Q4 2018

As of 31 Dec 2018, Syndax Pharmaceuticals Inc - Common Stock (SNDX) was held by 73 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,460,307 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, MPM ASSET MANAGEMENT LLC, BVF INC/IL, BlackRock Inc., 683 Capital Management, LLC, Vanguard Group Inc, DIMENSIONAL FUND ADVISORS LP, Sofinnova Investments, Inc., RENAISSANCE TECHNOLOGIES LLC, and BANK OF AMERICA CORP /DE/. This page lists 73 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders
73
Q4 2018 holders
73
Holder diff
0
Investor Q3 2018 Shares Q4 2018 Shares Share Diff Share Chg % Q3 2018 Value $ Q4 2018 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.